RPS19, RPS21 and RPS24 are found to be up-regulated in human cancerous prostate tissues, gathered from 82 patients, when compared with normal ones suggesting that these RPs could serve as biomarkers for PCa [46]. The gene discussed is RPS21; the disease is posterior cortical atrophy.